[
  {
    "ts": null,
    "headline": "Regenerative Drugs Market Review 2020-2024 and Forecast 2025-2030: A $29 Billion Opportunity Led by Baxter International, Stryker Corporation and Medtronic",
    "summary": "The regenerative drugs market offers significant opportunities in cell-based therapies and organ regeneration, addressing diverse medical fields like cardiovascular and neurology. Key players drive innovation, with Europe leading in cell therapies. Growing global demand and investment highlight potential for healthcare transformation. Global Regenerative Drugs Market Global Regenerative Drugs Market Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The \"Regenerative Drugs Market - Forecasts from 2025 t",
    "url": "https://finnhub.io/api/news?id=7667dede19549f30a20177a1834ccb10d35d56ce596982441c08ae18babe99a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758806100,
      "headline": "Regenerative Drugs Market Review 2020-2024 and Forecast 2025-2030: A $29 Billion Opportunity Led by Baxter International, Stryker Corporation and Medtronic",
      "id": 136883186,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "The regenerative drugs market offers significant opportunities in cell-based therapies and organ regeneration, addressing diverse medical fields like cardiovascular and neurology. Key players drive innovation, with Europe leading in cell therapies. Growing global demand and investment highlight potential for healthcare transformation. Global Regenerative Drugs Market Global Regenerative Drugs Market Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The \"Regenerative Drugs Market - Forecasts from 2025 t",
      "url": "https://finnhub.io/api/news?id=7667dede19549f30a20177a1834ccb10d35d56ce596982441c08ae18babe99a7"
    }
  },
  {
    "ts": null,
    "headline": "There's A Lot To Like About Stryker's (NYSE:SYK) Upcoming US$0.84 Dividend",
    "summary": "Stryker Corporation ( NYSE:SYK ) is about to trade ex-dividend in the next 4 days. The ex-dividend date is one business...",
    "url": "https://finnhub.io/api/news?id=e8ec856473bcd987abe4bda6d17712630fc53689fff6db0531fb183c1fd570a8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758798457,
      "headline": "There's A Lot To Like About Stryker's (NYSE:SYK) Upcoming US$0.84 Dividend",
      "id": 136883187,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "Stryker Corporation ( NYSE:SYK ) is about to trade ex-dividend in the next 4 days. The ex-dividend date is one business...",
      "url": "https://finnhub.io/api/news?id=e8ec856473bcd987abe4bda6d17712630fc53689fff6db0531fb183c1fd570a8"
    }
  },
  {
    "ts": null,
    "headline": "Craniomaxillofacial Devices Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034",
    "summary": "Growth is driven by increased facial injuries from accidents and sports, and congenital deformities in children. Advancements in biocompatible materials and imaging technologies facilitate precise, minimally invasive surgeries. The U.S. market, worth USD 794.6 million in 2024, benefits from high accident rates and innovations in medical devices. Key players, including Medtronic and Stryker, are enhancing portfolios with new technologies, contributing to the market's expansion. Craniomaxillofacia",
    "url": "https://finnhub.io/api/news?id=b5137568c456a096204edb304f0bf5885f2a02ec6b9e360f99f3bb26849257cd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758789840,
      "headline": "Craniomaxillofacial Devices Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034",
      "id": 136883188,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "Growth is driven by increased facial injuries from accidents and sports, and congenital deformities in children. Advancements in biocompatible materials and imaging technologies facilitate precise, minimally invasive surgeries. The U.S. market, worth USD 794.6 million in 2024, benefits from high accident rates and innovations in medical devices. Key players, including Medtronic and Stryker, are enhancing portfolios with new technologies, contributing to the market's expansion. Craniomaxillofacia",
      "url": "https://finnhub.io/api/news?id=b5137568c456a096204edb304f0bf5885f2a02ec6b9e360f99f3bb26849257cd"
    }
  },
  {
    "ts": null,
    "headline": "Single Use Surgical Instruments Market - Global Forecast to 2030 | Single-Use Surgical Instruments Market to Hit USD 7.80 Billion by 2030, Driven by ASCs Demand",
    "summary": "Increasing demand from outpatient and ambulatory surgical centers (ASCs) is driving market growth, as these facilities require efficient, sterile, and cost-effective solutions. Single-use instruments eliminate reprocessing costs and reduce cross-contamination risks, making them ideal for ASCs. Key players include Ethicon, Medtronic, BD, B. Braun, and Stryker. The market offers opportunities due to emerging healthcare infrastructure and challenges with environmental sustainability. Global Single",
    "url": "https://finnhub.io/api/news?id=399ebec08c533ea44e55c52bf560c32adf8fec210924a6be74e767079edef732",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758787260,
      "headline": "Single Use Surgical Instruments Market - Global Forecast to 2030 | Single-Use Surgical Instruments Market to Hit USD 7.80 Billion by 2030, Driven by ASCs Demand",
      "id": 136883189,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "Increasing demand from outpatient and ambulatory surgical centers (ASCs) is driving market growth, as these facilities require efficient, sterile, and cost-effective solutions. Single-use instruments eliminate reprocessing costs and reduce cross-contamination risks, making them ideal for ASCs. Key players include Ethicon, Medtronic, BD, B. Braun, and Stryker. The market offers opportunities due to emerging healthcare infrastructure and challenges with environmental sustainability. Global Single",
      "url": "https://finnhub.io/api/news?id=399ebec08c533ea44e55c52bf560c32adf8fec210924a6be74e767079edef732"
    }
  }
]